CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands |
Total |
Common Stock |
Additional Paid-In Capital |
Accumulated Other Comprehensive Income (Loss) |
Accumulated Deficit |
| Beginning Balance at Dec. 31, 2024 |
$ 96,664
|
$ 13
|
$ 553,623
|
$ 22
|
$ (456,994)
|
| Beginning Balance, Shares at Dec. 31, 2024 |
|
6,238,799
|
|
|
|
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes, and exercise of stock options |
(55)
|
|
(55)
|
|
|
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes, and exercise of stock options, shares |
|
3,769
|
|
|
|
| Issuance costs for private placement |
12
|
|
12
|
|
|
| Stock-based compensation expense |
1,933
|
|
1,933
|
|
|
| Other comprehensive income (loss) |
1
|
|
|
1
|
|
| Net loss |
(32,486)
|
|
|
|
(32,486)
|
| Ending Balance at Mar. 31, 2025 |
66,069
|
$ 13
|
555,513
|
23
|
(489,480)
|
| Ending Balance, Shares at Mar. 31, 2025 |
|
6,242,568
|
|
|
|
| Beginning Balance at Dec. 31, 2024 |
96,664
|
$ 13
|
553,623
|
22
|
(456,994)
|
| Beginning Balance, Shares at Dec. 31, 2024 |
|
6,238,799
|
|
|
|
| Other comprehensive income (loss) |
(10)
|
|
|
|
|
| Net loss |
(2,418,839)
|
|
|
|
|
| Ending Balance at Sep. 30, 2025 |
(2,225,487)
|
$ 15
|
650,319
|
12
|
(2,875,833)
|
| Ending Balance, Shares at Sep. 30, 2025 |
|
9,026,922
|
|
|
|
| Beginning Balance at Mar. 31, 2025 |
66,069
|
$ 13
|
555,513
|
23
|
(489,480)
|
| Beginning Balance, Shares at Mar. 31, 2025 |
|
6,242,568
|
|
|
|
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes, exercise of stock options, and issuance of common stock under ESPP |
65
|
|
65
|
|
|
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes, exercise of stock options, and issuance of common stock under ESPP, Shares |
|
39,721
|
|
|
|
| Stock-based compensation expense |
1,844
|
|
1,844
|
|
|
| Other comprehensive income (loss) |
(9)
|
|
|
(9)
|
|
| Net loss |
(1,573,669)
|
|
|
|
(1,573,669)
|
| Ending Balance at Jun. 30, 2025 |
(1,505,700)
|
$ 13
|
557,422
|
14
|
(2,063,149)
|
| Ending Balance, Shares at Jun. 30, 2025 |
|
6,282,289
|
|
|
|
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes, and exercise of stock options |
1,935
|
|
1,935
|
|
|
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes, and exercise of stock options, shares |
|
58,210
|
|
|
|
| Issuance of common stock from at-the-market sales agreement, net of commissions, Shares |
|
540,750
|
|
|
|
| Issuance of common stock from at-the-market sales agreement, net of commissions |
20,257
|
$ 1
|
20,256
|
|
|
| Stock-based compensation expense |
8,029
|
|
8,029
|
|
|
| Issuance of common stock from exercise of pre-funded warrants |
62,678
|
$ 1
|
62,677
|
|
|
| Issuance of common stock from exercise of pre-funded warrants, shares |
|
2,145,673
|
|
|
|
| Other comprehensive income (loss) |
(2)
|
|
|
(2)
|
|
| Net loss |
(812,684)
|
|
|
|
(812,684)
|
| Ending Balance at Sep. 30, 2025 |
(2,225,487)
|
$ 15
|
650,319
|
12
|
(2,875,833)
|
| Ending Balance, Shares at Sep. 30, 2025 |
|
9,026,922
|
|
|
|
| Beginning Balance at Dec. 31, 2025 |
$ (164,312)
|
$ 18
|
988,604
|
41
|
(1,152,975)
|
| Beginning Balance, Shares at Dec. 31, 2025 |
38,720,196
|
38,720,196
|
|
|
|
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes, and exercise of stock options |
$ (2)
|
|
(2)
|
|
|
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes, and exercise of stock options, shares |
|
352
|
|
|
|
| Issuance of common stock from private placement, net of issuance costs, shares |
|
5,338,078
|
|
|
|
| Issuance of common stock from private placement, net of issuance costs |
74,906
|
|
74,906
|
|
|
| Stock-based compensation expense |
8,870
|
|
8,870
|
|
|
| Issuance of common stock from exercise of pre-funded warrants |
150,446
|
$ 1
|
150,445
|
|
|
| Issuance of common stock from exercise of pre-funded warrants, shares |
|
10,126,956
|
|
|
|
| Other comprehensive income (loss) |
(747)
|
|
|
(747)
|
|
| Net loss |
(219,582)
|
|
|
|
(219,582)
|
| Ending Balance at Mar. 31, 2026 |
(150,421)
|
$ 19
|
1,222,823
|
(706)
|
(1,372,557)
|
| Ending Balance, Shares at Mar. 31, 2026 |
|
54,185,582
|
|
|
|
| Beginning Balance at Dec. 31, 2025 |
$ (164,312)
|
$ 18
|
988,604
|
41
|
(1,152,975)
|
| Beginning Balance, Shares at Dec. 31, 2025 |
38,720,196
|
38,720,196
|
|
|
|
| Other comprehensive income (loss) |
$ (1,886)
|
|
|
|
|
| Net loss |
(369,119)
|
|
|
|
|
| Ending Balance at Sep. 30, 2026 |
$ (137,173)
|
$ 20
|
1,386,746
|
(1,845)
|
(1,522,094)
|
| Ending Balance, Shares at Sep. 30, 2026 |
61,429,555
|
61,429,555
|
|
|
|
| Beginning Balance at Mar. 31, 2026 |
$ (150,421)
|
$ 19
|
1,222,823
|
(706)
|
(1,372,557)
|
| Beginning Balance, Shares at Mar. 31, 2026 |
|
54,185,582
|
|
|
|
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes, and exercise of stock options |
(2)
|
|
(2)
|
|
|
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes, and exercise of stock options, shares |
|
295
|
|
|
|
| Issuance costs for private placement |
(14)
|
|
(14)
|
|
|
| Stock-based compensation expense |
9,399
|
|
9,399
|
|
|
| Issuance of common stock from exercise of pre-funded warrants |
3,867
|
|
3,867
|
|
|
| Issuance of common stock from exercise of pre-funded warrants, shares |
|
269,874
|
|
|
|
| Other comprehensive income (loss) |
(216)
|
|
|
(216)
|
|
| Net loss |
(62,810)
|
|
|
|
(62,810)
|
| Ending Balance at Jun. 30, 2026 |
(200,197)
|
$ 19
|
1,236,073
|
(922)
|
(1,435,367)
|
| Ending Balance, Shares at Jun. 30, 2026 |
|
54,455,751
|
|
|
|
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes, exercise of stock options, and issuance of common stock under ESPP |
254
|
|
254
|
|
|
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes, exercise of stock options, and issuance of common stock under ESPP, Shares |
|
65,639
|
|
|
|
| Issuance of common stock from at-the-market sales agreement, net of commissions, Shares |
|
2,558,569
|
|
|
|
| Issuance of common stock from at-the-market sales agreement, net of commissions |
48,396
|
|
48,396
|
|
|
| Stock-based compensation expense |
9,942
|
|
9,942
|
|
|
| Issuance of common stock from exercise of pre-funded warrants |
92,082
|
$ 1
|
92,081
|
|
|
| Issuance of common stock from exercise of pre-funded warrants, shares |
|
4,349,596
|
|
|
|
| Other comprehensive income (loss) |
(923)
|
|
|
(923)
|
|
| Net loss |
(86,727)
|
|
|
|
(86,727)
|
| Ending Balance at Sep. 30, 2026 |
$ (137,173)
|
$ 20
|
$ 1,386,746
|
$ (1,845)
|
$ (1,522,094)
|
| Ending Balance, Shares at Sep. 30, 2026 |
61,429,555
|
61,429,555
|
|
|
|